Search results
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
Zacks via Yahoo Finance· 4 hours agoWhile the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals,...
US CDC warns of harmful reactions to fake Botox injections
Reuters via Yahoo News· 1 day agoA total of 22 people from 11 U.S. states reported adverse effects after receiving Botox injections...
AbbVie Study on Treatment for Giant Cell Arteritis Meets Primary Endpoint
Market Watch· 6 days agoAbbVie disclosed positive top-line results from a study on upadacitinib to treat adults with giant cell arteritis, an autoimmune disease. The drugmaker said its Phase 3 study ...
Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
The Wall Street Journal· 6 days agoAbbVie’s acquisition of neuroscience biotech Cerevel Therapeutics hasn’t closed yet. But the latest results from Cerevel’s Parkinson’s disease late-stage trial just made the ...
Fake Botox Has Made People Sick in Several States—Here's How to Avoid It
Health.com· 24 hours agoU.S. authorities have warned that counterfeit Botox products have sickened people around the country...
CDC issues health advisory about risks of counterfeit or mishandled Botox injections
CNN via Yahoo News· 1 day agoThe US Centers for Disease Control and Prevention issued an advisory Tuesday about the risks of...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LABP, ADTH, MODN, SCX
Clearfield Progress· 6 days agoLandos Biopharma, Inc. (NASDAQ: LABP)'s sale to AbbVie Inc. Under the terms of the proposed transaction, AbbVie would acquire Landos for $20.42 per share ...
EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)
Seeking Alpha· 2 days agoEU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...
US CDC warns of harmful reactions to fake Botox injections
Reuters· 1 day ago, opens new tab Botox that were given to consumers for cosmetic purposes in multiple states. A total...
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
InvestorPlace· 23 hours agoBecause dividend investing has such an impressive track record of beating non-dividend-paying...